Wells Fargo’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Buy |
44,043
+5,277
| +14% | +$290K | ﹤0.01% | 2789 |
|
|
2025
Q1 | $2.74M | Sell |
38,766
-19,177
| -33% | -$1.36M | ﹤0.01% | 2581 |
|
|
2024
Q4 | $3.81M | Sell |
57,943
-7,142
| -11% | -$469K | ﹤0.01% | 2331 |
|
|
2024
Q3 | $4.57M | Sell |
65,085
-69,081
| -51% | -$4.86M | ﹤0.01% | 2174 |
|
|
2024
Q2 | $11M | Sell |
134,166
-270,400
| -67% | -$22.3M | ﹤0.01% | 1517 |
|
|
2024
Q1 | $35.3M | Buy |
404,566
+195,003
| +93% | +$17M | 0.01% | 846 |
|
|
2023
Q4 | $20.2M | Sell |
209,563
-39,267
| -16% | -$3.79M | 0.01% | 1091 |
|
|
2023
Q3 | $22M | Buy |
248,830
+8,204
| +3% | +$726K | 0.01% | 970 |
|
|
2023
Q2 | $20.9M | Sell |
240,626
-103,088
| -30% | -$8.94M | 0.01% | 1047 |
|
|
2023
Q1 | $33.4M | Sell |
343,714
-6,406
| -2% | -$623K | 0.01% | 817 |
|
|
2022
Q4 | $36.2M | Buy |
350,120
+2,685
| +0.8% | +$278K | 0.01% | 767 |
|
|
2022
Q3 | $29.5M | Buy |
347,435
+17,932
| +5% | +$1.52M | 0.01% | 838 |
|
|
2022
Q2 | $27.3M | Sell |
329,503
-25,224
| -7% | -$2.09M | 0.01% | 924 |
|
|
2022
Q1 | $27.4M | Buy |
354,727
+58,349
| +20% | +$4.5M | 0.01% | 1076 |
|
|
2021
Q4 | $26.2M | Buy |
296,378
+62,642
| +27% | +$5.53M | 0.01% | 1097 |
|
|
2021
Q3 | $18.1M | Sell |
233,736
-24,227
| -9% | -$1.87M | ﹤0.01% | 1684 |
|
|
2021
Q2 | $21.5M | Sell |
257,963
-76,787
| -23% | -$6.41M | ﹤0.01% | 1584 |
|
|
2021
Q1 | $25.3M | Sell |
334,750
-214,799
| -39% | -$16.2M | 0.01% | 1440 |
|
|
2020
Q4 | $48.2M | Buy |
549,549
+11,218
| +2% | +$984K | 0.01% | 1003 |
|
|
2020
Q3 | $41M | Sell |
538,331
-589,175
| -52% | -$44.8M | 0.01% | 979 |
|
|
2020
Q2 | $139M | Buy |
1,127,506
+108,423
| +11% | +$13.4M | 0.04% | 413 |
|
|
2020
Q1 | $86.1M | Buy |
1,019,083
+497,363
| +95% | +$42M | 0.03% | 513 |
|
|
2019
Q4 | $44.1M | Sell |
521,720
-64,999
| -11% | -$5.5M | 0.01% | 996 |
|
|
2019
Q3 | $39.5M | Sell |
586,719
-121,474
| -17% | -$8.19M | 0.01% | 1035 |
|
|
2019
Q2 | $60.7M | Sell |
708,193
-12,026
| -2% | -$1.03M | 0.02% | 825 |
|
|
2019
Q1 | $64M | Sell |
720,219
-48,275
| -6% | -$4.29M | 0.02% | 749 |
|
|
2018
Q4 | $65.4M | Sell |
768,494
-196,039
| -20% | -$16.7M | 0.02% | 684 |
|
|
2018
Q3 | $93.5M | Buy |
964,533
+171,669
| +22% | +$16.6M | 0.03% | 616 |
|
|
2018
Q2 | $74.7M | Buy |
792,864
+45,881
| +6% | +$4.32M | 0.02% | 700 |
|
|
2018
Q1 | $60.6M | Sell |
746,983
-306,271
| -29% | -$24.8M | 0.02% | 800 |
|
|
2017
Q4 | $93.9M | Buy |
1,053,254
+382,415
| +57% | +$34.1M | 0.03% | 592 |
|
|
2017
Q3 | $62.4M | Sell |
670,839
-881,203
| -57% | -$82M | 0.02% | 756 |
|
|
2017
Q2 | $141M | Sell |
1,552,042
-350,675
| -18% | -$31.8M | 0.05% | 415 |
|
|
2017
Q1 | $167M | Sell |
1,902,717
-375,406
| -16% | -$33M | 0.05% | 353 |
|
|
2016
Q4 | $189M | Sell |
2,278,123
-103,693
| -4% | -$8.59M | 0.07% | 305 |
|
|
2016
Q3 | $220M | Sell |
2,381,816
-122,811
| -5% | -$11.4M | 0.08% | 260 |
|
|
2016
Q2 | $195M | Sell |
2,504,627
-152,185
| -6% | -$11.8M | 0.08% | 283 |
|
|
2016
Q1 | $219M | Buy |
2,656,812
+57,012
| +2% | +$4.7M | 0.09% | 256 |
|
|
2015
Q4 | $272M | Buy |
2,599,800
+991,740
| +62% | +$104M | 0.11% | 216 |
|
|
2015
Q3 | $169M | Buy |
1,608,060
+436,308
| +37% | +$46M | 0.07% | 316 |
|
|
2015
Q2 | $160M | Sell |
1,171,752
-41,246
| -3% | -$5.64M | 0.06% | 341 |
|
|
2015
Q1 | $151M | Sell |
1,212,998
-699,245
| -37% | -$87.1M | 0.06% | 355 |
|
|
2014
Q4 | $173M | Sell |
1,912,243
-1,040,567
| -35% | -$94.1M | 0.07% | 318 |
|
|
2014
Q3 | $213M | Buy |
2,952,810
+32,405
| +1% | +$2.34M | 0.09% | 271 |
|
|
2014
Q2 | $182M | Sell |
2,920,405
-547,340
| -16% | -$34.1M | 0.07% | 312 |
|
|
2014
Q1 | $237M | Sell |
3,467,745
-393,504
| -10% | -$26.8M | 0.1% | 242 |
|
|
2013
Q4 | $272M | Buy |
3,861,249
+1,430,600
| +59% | +$101M | 0.12% | 218 |
|
|
2013
Q3 | $175M | Sell |
2,430,649
-43,241
| -2% | -$3.12M | 0.08% | 288 |
|
|
2013
Q2 | $138M | Buy |
+2,473,890
| New | +$138M | 0.07% | 315 |
|